Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating Lipid Accumulation in the Right Ventricle of Patients with Pulmonary Arterial Hypertension

Official title: Clinical and Mechanistic Understanding of Right Ventricular Steatosis in Pulmonary Arterial Hypertension (PAH)

Run by Vanderbilt University Medical Center · NCT05462574 · Data updated 2026-11-12

This study is trying to see how fat buildup in the right side of the heart affects the health and exercise ability of people with pulmonary arterial hypertension.

More Pulmonary Arterial Hypertension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment75 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedJanuary 17, 2023
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedMay 29, 2026
Trial IDNCT05462574 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older diagnosed with idiopathic, heritable, or connective tissue disease-associated PAH who are stable on their medication regimen.

Probably not a fit

Patients with functional class IV heart failure or those unable to undergo necessary testing such as MRI/MRS may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between right ventricle (RV) lipid accumulation and RV function, exercise capacity, and clinical outcomes in patients with pulmonary arterial hypertension (PAH). The study will measure lipid levels in the RV and left ventricle, assess exercise capacity through tests like the 6-minute walk test, and analyze potential drivers of lipid accumulation, including BMPR2 expression and lipid metabolism. Participants will be followed over time to understand the natural history of RV steatosis and its impact on health.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of pulmonary arterial hypertension, potentially enhancing patient outcomes.

How similar studies have gone: While the specific focus on RV lipid accumulation in PAH is novel, related studies have shown promising results in understanding lipid metabolism in cardiovascular diseases.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* ≥ 18 years old
* Diagnosed with idiopathic, heritable, connective tissue disease-associated PAH, associated pulmonary arterial hypertension (PAH), or drug-or toxin-associated PAH according to World Health Organization (WHO) consensus recommendations.
* Stable PAH-specific medication regimen for three months prior to enrollment. Adjustments in IV prostacyclin for side effect management are allowed. Diuretic adjustments are permitted.
* WHO Functional Class I-III
* Ambulatory
* Able to have an MRI/MRS, perform a 6MWD test, and cardiopulmonary exercise test

Exclusion criteria:

* Pregnancy
* Diagnosis of PAH etiology other than idiopathic, heritable, connective tissue disease - associated PAH or associated with drugs and toxins
* WHO Functional class IV heart failure
* Requirement for continuous oxygen
* Unable to have an MRI/MRS, perform a 6MWD test, or cardiopulmonary exercise test.
* Patients with implanted/embedded ferromagnetic material that would preclude cardiac MRI

Where it's running

  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.